Summary
Changes in plasma insulin in response to a physiological or pathophysiological elevation in circulating atrial natriuretic factor (ANF) have been investigated.
Plasma insulin, glucose, immunoreactive (ir) ANF, effective renal plasma flow (ERPF), glomerular filtration rate (GFR), absolute and fractional excretion of sodium (FENa), have been measured in 14 volunteers before and during infusion of low doses of ANF or vehicle (V). Each subject received single-blind in a randomized sequence at 2 week-intervals: V alone, or ANF 4, 8 and 16 ng·kg−1·min−1, indused over 90 min.
Plasma irANF was increased 2.5- to 11-fold during the ANF infusion as compared to the test with the vehicle. Plasma insulin did not change during V administration (baseline vs V: 22 vs 21 μU·ml−1) and was unchanged during ANF at 4, 8 and 16 ng·kg−1·min−1 (19, 19, 21 μU·ml−1, respectively). Blood pressure, ERPF and GFR were not affected, and diuresis, FENa and urinary Na excretion were increased significantly and dose-dependently during ANF, but not V infusion. Compared to baseline, ANF 4, 8 and 16 ng·kg−1·min−1 increased urinary Na excretion by 147, 241 and 446 μmol·min−1, respectively.
The findings indicate that, in normal humans, an acute increase in irANF within or slightly above the physiological range, which modified natriuresis and diuresis, did not alter circulating plasma insulin.
References
Lang RE, Unger T, Ganten D (1987) Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens 5: 255–271
Weidmann P, Saxenhofer H, Ferrier C, Shaw SG (1988) Atrial natriuretic peptide in man. Am J Nephrol 8: 1–14
Cottier C, Matter L, Weidmann P, Shaw S, Gnädinger MP (1988) Renal response to low-dose infusion of atrial natriuretic peptide in normal man. Kidney Int 34 (Suppl 25): 72–78
Janssen WMT, De Zeeuw D, Van der Hem GK, De Jong PE (1989) Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension 13: 640–646
Richards MA, Espiner EA, Ikram H, Yandle TG (1989) Atrial natriuretic factor in hypertension: Bioactivity at normal plasma levels. Hypertension 14: 261–268
Uehlinger DE, Weidmann P, Gnädinger MP, Hasler L, Bachmann C, Shaw S, Helmüller B, Lang RE (1986) Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol 8: 1122–1129
Weidmann P, Gnädinger MP, Ziswiler HR, Shaw S, Bachmann C, Rascher W, Uehlinger DE, Hasler L, Reubi FC (1986) Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertension 4 [Suppl 2]: 71–83
De Fronzo RA (1981) The effect of insulin on renal sodium metabolism. Diabetologia 21: 165–171
Sealey JE, Gerten-Banes J, Laragh JH (1972) The renin system: variations in man measured by radioimmunoassay or bioassay. Kidney Int 1: 240–253
Malvano R, Gandolfi C, Giannessi D, Giannotti P, Grosso P (1976) Radioimmunoassay of aldosterone in crude plasma extracts. J Nucl Biol Med 20: 37–44
Shaw SG, Weidmann P (1988) Potential pitfalls in the radioimmunoassay of physiological plasma levels of atrial natriuretic peptide. Z Kardiol 77 [Suppl 2]: 26–30
Laychock SG (1981) Evidence for guanosine 3′, 5′-monophosphate as a putative mediator of insulin secretion from isolated rat islets. Endocrinology 108: 1197–1205
Tremblay J, Gerzer R, Vinay P, Pang SC, Beliveau R, Hamet P (1985) The increase in cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett 181: 17–22
Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH (1986) Effect of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J Clin Endocrinol Metab 62: 1027–1036
Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC (1986) Blood levels and renal effects of atrial natriuretic peptide in normal humans. J Clin Invest 77: 734–742
Marin-Grez M, Felming JT, Steinhausen M (1986) Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney. Nature 324: 473–476
Author information
Authors and Affiliations
Additional information
The work was supported in part by the Swiss National Science Foundation
Rights and permissions
About this article
Cite this article
Ferrari, P., Shaw, S., Riesen, W. et al. Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor. Eur J Clin Pharmacol 42, 453–455 (1992). https://doi.org/10.1007/BF00280135
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280135